# Acupuncture to Reduce Chemotherapy-induced Peripheral Neuropathy Severity During Neoadjuvant or Adjuvant Weekly Paclitaxel Chemotherapy in Breast Cancer Patients

> **NCT02364726** · NA · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 28 (actual)

## Conditions studied

- Breast Cancer
- Peripheral Neuropathy

## Interventions

- **PROCEDURE:** Acupuncture
- **BEHAVIORAL:** Neuropathic Pain Scale (NPS) questionnaire
- **BEHAVIORAL:** FACT/GOG-Ntx questionnaire

## Key facts

- **NCT ID:** NCT02364726
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02-09
- **Primary completion:** 2023-06-21
- **Final completion:** 2023-06-21
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2023-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02364726

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02364726, "Acupuncture to Reduce Chemotherapy-induced Peripheral Neuropathy Severity During Neoadjuvant or Adjuvant Weekly Paclitaxel Chemotherapy in Breast Cancer Patients". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02364726. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*